Target intelligence / Profile preview

Cleavage factor polyribonucleotide kinase subunit 1 (CLP1)

Target
CLP1
Molecular classification
Enzyme, Polynucleotide kinase, RNA processing factor, Component of tRNA splicing endonuclease complex, Component of mRNA pre-mRNA cleavage complex II (CF-II)
01

Overview

Cleavage factor polyribonucleotide kinase subunit 1 (CLP1) is a multifunctional **polynucleotide kinase enzyme** that phosphorylates 5'-hydroxyl groups on a variety of polynucleotide substrates, including double-stranded RNA, single-stranded RNA, double-stranded DNA, and DNA:RNA hybrids, with a particular efficiency toward RNA substrates[1][2][3]. It is an essential component of both the **tRNA splicing endonuclease complex**—required for the maturation and ligation of tRNA exons—and the **pre-mRNA cleavage complex II (CF-II)** involved in the 3'-end processing of mRNA precursors[1][2][3]. CLP1 also plays a role in the maturation of small interfering RNAs (siRNAs). Defects in CLP1 disrupt tRNA and mRNA processing and are causatively linked to the human neurodevelopmental disease **pontocerebellar hypoplasia type 10 (PCH10)**, characterized by microcephaly and progressive neurodegeneration[1][2][5][7]. This underscores CLP1’s importance in gene expression, especially in neuronal development and survival. No specific drugs or clinical inhibitors currently target CLP1, but its essential, highly conserved enzymatic role in RNA metabolism positions it as a potential target in the modulation of RNA processing pathways[1][2][5].

Other names
Polyribonucleotide 5'-hydroxyl-kinase Clp1HEABhClp1Polyadenylation factor Clp1Polynucleotide kinase Clp1Pre-mRNA cleavage complex II protein Clp1ATP/GTP-binding protein, cleavage and polyadenylation factor I subunit 1homolog of yeast CFIA subunit Clp1p
02

Biological functions

tRNA splicing and maturationmRNA 3'-end formationsiRNA maturationPhosphorylation of 5'-hydroxyl groups on polynucleotidesRegulation of RNA metabolism
03

Disease associations

Neurodegenerative disease (e.g., pontocerebellar hypoplasia type 10)Potential role in neurodevelopmental disordersOther (related to tRNA and RNA processing defects)
04

Safety considerations

Loss of function mutations cause severe neurodevelopmental defects, including progressive neurodegeneration[1][2][5]Essential for proper neuronal development and survival, so inhibition or dysfunction could result in toxicity, especially in the nervous system[2]
05

Biomarkers

CLP1 gene mutations may serve as biomarkers for pontocerebellar hypoplasia type 10[1][2][5]

Beyond the preview

Go deeper on Cleavage factor polyribonucleotide kinase subunit 1 (CLP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cleavage factor polyribonucleotide kinase subunit 1 (CLP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call